Search research articles
Contact Us
Filters
Showing results (71-80 of 140) with videos related to
Page
of 14
Sort By:
Plos One
|
August 11, 2021
Excess cost of care associated with sepsis in cancer patients: Results from a population-based case-control matched cohort
Michelle Tew, Kim Dalziel, Karin Thursky, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
October 30, 2024
Using QALYs as an Outcome for Assessing Global Prediction Accuracy in Diabetes Simulation Models
Helen A Dakin, Ni Gao, José Leal, et al.
Journal of the American Heart Association
|
March 24, 2021
Cost-Effectiveness of Combination Therapy for Patients With Systemic Sclerosis-Related Pulmonary Arterial Hypertension
An Tran-Duy, Kathleen Morrisroe, Philip Clarke, et al.
Pharmacoeconomics
|
June 26, 2024
Estimating Risk Factor Time Paths Among People with Type 2 Diabetes and QALY Gains from Risk Factor Management
Ni Gao, Helen A Dakin, Rury R Holman, et al.
Pharmacoeconomics
|
November 23, 2016
How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review
Xinyang Hua, Thomas Wai-Chun Lung, Andrew Palmer, et al.
European Journal of Preventive Cardiology
|
July 28, 2017
Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort
Xinyang Hua, Robyn McDermott, Thomas Lung, et al.
Plos Medicine
|
November 30, 2021
Disease-related income and economic productivity loss in New Zealand: A longitudinal analysis of linked individual-level data
Tony Blakely, Finn Sigglekow, Muhammad Irfan, et al.
Lancet (London, England)
|
May 21, 2024
Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)
Amanda I Adler, Ruth L Coleman, Jose Leal, et al.
Tobacco Control
|
December 5, 2023
Economic effects for citizens and the government of a country-level tobacco endgame strategy: a modelling study
Driss Ait Ouakrim, Tim Wilson, Samantha Howe, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 5, 2026
Health Utilities and Disutilities Associated with Complications of Type 1 Diabetes: A Systematic Review and Recommendations for Health Economic Models
An Tran-Duy, Ting Zhao, Liam Fernando-Canavan, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 140) with videos related to
Sort By:
Page
of 14
Plos One
|
August 11, 2021
Excess cost of care associated with sepsis in cancer patients: Results from a population-based case-control matched cohort
Michelle Tew, Kim Dalziel, Karin Thursky, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
October 30, 2024
Using QALYs as an Outcome for Assessing Global Prediction Accuracy in Diabetes Simulation Models
Helen A Dakin, Ni Gao, José Leal, et al.
Journal of the American Heart Association
|
March 24, 2021
Cost-Effectiveness of Combination Therapy for Patients With Systemic Sclerosis-Related Pulmonary Arterial Hypertension
An Tran-Duy, Kathleen Morrisroe, Philip Clarke, et al.
Pharmacoeconomics
|
June 26, 2024
Estimating Risk Factor Time Paths Among People with Type 2 Diabetes and QALY Gains from Risk Factor Management
Ni Gao, Helen A Dakin, Rury R Holman, et al.
Pharmacoeconomics
|
November 23, 2016
How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review
Xinyang Hua, Thomas Wai-Chun Lung, Andrew Palmer, et al.
European Journal of Preventive Cardiology
|
July 28, 2017
Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort
Xinyang Hua, Robyn McDermott, Thomas Lung, et al.
Plos Medicine
|
November 30, 2021
Disease-related income and economic productivity loss in New Zealand: A longitudinal analysis of linked individual-level data
Tony Blakely, Finn Sigglekow, Muhammad Irfan, et al.
Lancet (London, England)
|
May 21, 2024
Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)
Amanda I Adler, Ruth L Coleman, Jose Leal, et al.
Tobacco Control
|
December 5, 2023
Economic effects for citizens and the government of a country-level tobacco endgame strategy: a modelling study
Driss Ait Ouakrim, Tim Wilson, Samantha Howe, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 5, 2026
Health Utilities and Disutilities Associated with Complications of Type 1 Diabetes: A Systematic Review and Recommendations for Health Economic Models
An Tran-Duy, Ting Zhao, Liam Fernando-Canavan, et al.
Page
of 14